Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities fraud at Hospira, Inc. (“Hospira” or the “Company”) (NYSE: HSP).

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) Hospira was experiencing major quality control issues which jeopardized the financial viability of the Company’s “Project Fuel” program – which was designed to optimize Hospira shareholder value; (2) Hospira was unable to remedy problems identified in FDA Warning Letters related to the Company’s infusion pumps, quality control deficiencies and manufacturing weaknesses; (3) Company revenue guidance for 2010 and 2011 was inaccurate and lacked a reasonable basis when made; and (4) the Company and certain individuals’ statements regarding the Company’s financial performance and expected earnings were false and misleading and lacked a reasonable basis when made.

Request more information now by clicking here: www.faruqilaw.com/HSP

On October 18, 2011, Hospira announced disappointing preliminary third quarter financial results and slashed full-year guidance, blaming a production disruption at the Company’s Rocky Mount, North Carolina factory, responsible for roughly 25% of Hospira sales. The result of the Company’s negative results was a 21% drop in the price of Hospira common stock, which fell $7.85 per share to close at $29.51 per share on October 18, 2011.

Take Action

If you purchased Hospira securities between March 24, 2009, and October 17, 2011, and would like to discuss your legal rights, visit www.faruqilaw.com/HSP. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Hospira’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter.

Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Hospira.
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Hospira.